section name header

Y-Site Injection Compatibility (1:1 Mixture)

Eravacycline dihydrochloride

(Mfr: TET)(Conc: 0.6 mg/mLa)

I

Albumin human

(Mfr: BXT)(Conc: 250 mg/mL)

Remarks:

Measured turbidity increased immediately

Ref:

3532